Abstract 944: Pre-clinical activity of the Wnt pathway inhibitor RXC004 in combination with MAPK pathway inhibitors in GI cancer modelsSimon A. Woodcock, C. W. Phillips, Catherine Eagle et al.|Cancer Research|2024Cited by 1